Market Tracker

06/28 5:16pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

125.81
Delayed Data
As of Jun 28
 +3.70 / +3.03%
Today’s Change
96.18
Today|||52-Week Range
145.42
+2.83%
Year-to-Date

Today’s Trading

Previous close122.11
Today’s open122.35
Day’s range121.51 - 126.52
Volume2,473,762
Average volume (3 months)2,738,561
Market cap$27.4B
Dividend yield--
Data as of 4:00pm ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)+162.69%
Earnings growth (this year)+14.88%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+21.11%
P/E ratio59.9
Price/Sales9.22
Price/Book3.15

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+4.02+3.08%
ZTSZoetis Inc+0.19+0.30%
VRTXVertex Pharmaceutica...+1.88+1.45%
BAXBaxter International...+0.18+0.30%
Data as of 4:01pm ET, 06/28/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$1.25
Annual revenue (last year)$3.0B
Annual profit (last year)$399.0M
Net profit margin13.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts